Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Pumpers are in hiding again

<< Previous

Bullboard Posts

Next >>

Comment by MinimumDamageon Mar 31, 2021 1:06pm

77 Views

Post# 32914971

RE:Pumpers are in hiding again

losingmyshirt - (3/31/2021 10:28:18 AM)
Pumpers are in hiding again

It's because they prefer to go back to their safe space at the WorkinMontana / Kalyterana HQ. You're to grounded and way to REAListic for their soft psychological barriers.

As south park eloquently put it :

https://www.youtube.com/watch?v=sXQkXXBqj_U

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading